AtriCure grows sales by 21% in Q4
AtriCure (NYSE: ATRC) shares dipped today despite fourth-quarter results that came in ahead of the consensus forecast.
Source: massdevice.com
Page 5 - Massdevice Medtech News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Massdevice Medtech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Massdevice Medtech Today - Breaking & Trending Today
How GLP-1s tanked and reshaped the medtech stock market
Promising clinical trial results on glucagon-like peptide 1 agonists (GLP-1s) created a seismic shift in the medtech stock market.
Source: massdevice.com
Embecta beats The Street in Q1, raises guidance
Embecta (Nasdaq:EMBC) shares took a hit this morning despite Street-beating first-quarter results and increased 2024 guidance.
Source: massdevice.com
Zimmer Biomet stock dips despite Street-beating Q4
Zimmer Biomet (NYSE: ZBH) shares slipped this morning despite fourth-quarter results that topped the consensus forecast.
Source: massdevice.com
Baxter beats The Street in Q4, kidney care spin progresses
Baxter (NYSE: BAX) shares ticked up today on fourth-quarter results that came in ahead of the consensus forecast.
Source: massdevice.com